Chemical Compound

Neratinib

CAS Registry Number 698387-09-6
Neratinib chemical structure
Primary Record

Neratinib

In stock
5,174 g
Purity
99.7 %
CAS
698387-09-6

Compound Identifiers & Properties

CAS
698387-09-6
PubChem CID
9915743
SMILES
CCOC1=C(C=C2C(=C1)N=CC(=C2NC3=CC(=C(C=C3)OCC4=CC=CC=N4)Cl)C#N)NC(=O)/C=C/CN(C)C
Canonical SMILES
CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C

Names & Synonyms

  • Neratinib
  • 698387-09-6
  • Nerlynx
  • HKI-272
  • Neratinib (HKI-272)
  • neratinibum
  • Neratinib maleate
  • Neratinib [USAN]
  • JJH94R3PWB
  • Neratinib (Standard)
  • Neratinib Impurity 3
  • HKI 272
  • Neratinib [USAN:INN]
  • Neratinib HKI 272
  • UNII-JJH94R3PWB
  • Tube708
  • NERATINIB [INN]
  • RefChem:56993
  • NERATINIB [MI]
  • Neratinib(HKI-272)
  • Neratinib (USAN/INN)
  • Neratinib - HKI-272
  • C30H29ClN6O3
  • cc-32
  • D0Q9CY
  • NERATINIB [MART.]
  • CDP-820
  • NERATINIB [WHO-DD]
  • CHEMBL180022
  • HKI272
  • Neratinib (HKI-272)?
  • MFCD09752958
  • PB-272
  • JSPY-st000262
  • CHEBI:61397
  • Neratinib (ERBB2 inhibitor)
  • SCHEMBL571762
  • DTXSID70220132
  • Neratinib - Bio-X trade mark
  • PB 272
  • GTPL5686
  • orb1305687
  • SCHEMBL29376313
  • SCHEMBL29394766
  • 698387-09-6 (free base)
  • AMY9255
  • DTXCID70142623
  • EX-A062
  • L10XE45
  • QCR-104
  • SYN1140
  • Neratinib(HKI-272)/HKI272
  • BCPP000151
  • GLXC-90246
  • HMS5087D17
  • WAY-179272
  • AOB87125
  • ZINC3916214
  • ABP000871
  • AN-546
  • BDBM50161957
  • EBC-27314
  • HY-32721R
  • NSC757439
  • NSC800803
  • s2150
  • WAY-179272-B
  • AKOS005146340
  • AKOS025149637
  • ACN-039807
  • BCP9000984
  • CCG-270036
  • CID9915743
  • CS-0035
  • DB11828
  • FN65101
  • NSC-757439
  • NSC-800803
  • RL04677
  • SDCCGSBI-0654392.P001
  • CID 9915743
  • NCGC00241101-01
  • NCGC00241101-03
  • NCGC00241101-08
  • NCGC00241101-09
  • AC-25073
  • AS-16279
  • BC256322
  • BN164645
  • BP-44032
  • HY-32721
  • SC-28031
  • (2E)-N-[4-[[3-chloro-4-[(pyridin-2-yl)methoxy]phenyl]amino]-3-cyano-7-ethoxyquinolin-6-yl]-4-(dimethylamino)but-2-enamide
  • AB0008022
  • A8322
  • FT-0696498
  • N1062
  • NS00069565
  • X2638
  • EC-000.2260
  • J2.688.659G
  • A10638
  • A25338
  • D08950
  • Z-3202
  • (E)-N-(4-((3-Chloro-4-(pyridin-2-ylmethoxy)phenyl)amino)-3-cyano-7-ethoxyquinolin-6-yl)-4-(dimethylamino)but-2-enamide
  • (E)-N-(4-(3-chloro-4-(pyridin-2-ylmethoxy)phenylamino)-3-cyano-7-ethoxyquinolin-6-yl)-4-(dimethylamino)but-2-enamide
  • EN300-7386009
  • 387N096
  • I06-2375
  • Q6995920
  • BRD-K85606544-001-01-8
  • BRD-K85606544-001-09-1
  • (2E)-N-(4-{[3-chloro-4-(pyridin-2-ylmethoxy)phenyl]amino}-3-cyano-7-ethoxyquinolin-6-yl)-4-(dimethylamino)but-2-enamide
  • (2E)-N-[4-[[3-Chloro-4-(2-pyridinylmethoxy)phenyl]amino]-3-cyano-7-ethoxy-6-quinolinyl]-4-(dimethylamino)-2-butenamide
  • B0084-347125
  • N0001-009020
  • (2e)-n-(4-((3-chloro-4-((pyridin-2-yl)methoxy)phenyl)amino)-3-cyano-7-ethoxyquinolin-6-yl)-4-(dimethylamino)but-2-enamide
  • (E)-N-[4-[3-chloro-4-(pyridin-2-ylmethoxy)anilino]-3-cyano-7-ethoxyquinolin-6-yl]-4-(dimethylamino)but-2-enamide
  • 2-Butenamide, N-(4-((3-chloro-4-(2-pyridinylmethoxy)phenyl)amino)-3-cyano-7-ethoxy-6-quinolinyl)-4-(dimethylamino)-, (2E)-
  • 876310-02-0
  • N-(4-(3-Chloro-4-(2-pyridinylmethoxy)anilino)-3-cyano-7-ethoxy-6-quinolyl)-4-(dimethylamino)-2-butenamide
  • 698387-09-6, HKI272, HKI 272, HKI-272,
  • (2E)-N-[4-({3-chloro-4-[(pyridin-2-yl)methoxy]phenyl}amino)-3-cyano-7-ethoxyquinolin-6-yl]-4-(dimethylamino)but-2-enamide
  • (E)-N-[4-[3-chloro-4-(2-pyridylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolyl]-4-(dimethylamino)but-2-enamide
  • Neratinib, 99%, a highly selective HER2 and EGFR inhibitor - 10MG 10mg
  • (2e)-n-(4-((3-chloro-4-((pyridin-2-yl)methoxy)phenyl)amino)-3-cyano-7-ethoxyquinolin-6-yl)-4-(dimethylamino)but-2-enamide neratinib
  • (2E)-N-(4-((3-chloro-4-(pyridin-2-ylmethoxy)phenyl)amino)-3-cyano-7-ethoxyquinolin-6-yl)-4-(dimethylamino)but-2-enamide
  • (2E)-N-(4-{3-Chloro-4-[(pyridin-2-yl)methoxy]anilino}-3-cyano-7-ethoxyquinolin-6-yl)-4-(dimethylamino)but-2-enamide
  • (E)-4-Dimethylamino-but-2-enoic acid {4-[3-chloro-4-(pyridin-2-ylmethoxy)-phenylamino]-3-cyano-7-ethoxy-quinolin-6-yl}-amide
  • (E)-N-(4-(3-chloro-4-(pyridin-2-ylmethoxy)phenylamino)-3-cyano-7-ethoxyquinolin-6-yl)-4-(dimethylami
  • (E)-N-[3-Cyano-4-[[4-(2-pyridylmethoxy)-3-chlorophenyl]amino]-7-ethoxyquinoline-6-yl]-4-(dimethylamino)-2-buteneamide
  • (E)-N-[4-[[3-Chloro-4-(2-pyridinylmethoxy)phenyl]amino]-3-cyano-7-ethoxy-6-quinolinyl]-4-(dimethylamino)-2-buteneamide
  • -N-[4-[[3-chloro-4-[ methoxy]phenyl]amino]-3-cyano-7-ethoxyquinolin-6-yl]-4- but-2-enamide
  • 2-Butenamide, N-[4-[[3-chloro-4-(2-pyridinylmethoxy)phenyl]amino]-3-cyano-7-ethoxy-6-quinolinyl]-4-(dimethylamino)-, (2E)-
  • 2-Butenamide, N-[4-[[3-chloro-4-(2-pyridinylmethoxy)phenyl]amino]-3-cyano-7-ethoxy-6-quinolinyl]-4-(dimethylamino)-, (2E)-; (2E)-N-[4-[[3-Chloro-4-(2-pyridinylmethoxy)phenyl]amino]-3-cyano-7-ethoxy-6-quinolinyl]-4-(dimethylamino)-2-butenamide; (E)-N-[4-[3-Chloro-4-[(2-pyridinyl)methoxy]anilino]-3-cyano-7-ethoxy-6-quinolinyl]-4-(dimethylamino)-2-butenamide; (E)-N-[4-[[3-Chloro-4-((pyridin-2-yl)methoxy)phenyl]amino]-3-cyano-7-ethoxyquinolin-6-yl]-4-(dimethylamino)-2-butenamide; HKI 272; Neratinib
  • 4-Dimethylamino-but-2-enoic acid {4-[3-chloro-4-(pyridin-2-ylmethoxy)-phenylamino]-3-cyano-7-ethoxy-quinolin-6-yl}-amide
  • N-(4-(3-chloro-4-(pyridin-2-ylmethoxy)phenylamino)-3-cyano-7-ethoxyquinolin-6-yl)-4-(dimethylamino)but-2-enamide
  • N-(4-(3-chloro-4-(pyridin-2-ylmethoxy)phenylamino)-3-cyano-7-ethoxyquinolin-6-yl)-4-(dimethylamino)butanamide